| S No. |
Date |
Drug List |
Price In USD |
Action |
| 1 |
Jun, 2020 |
Humira Drug Sales & Forecast
Humira (adalimumab) is a biologic therapy administered as a subcutaneous injection. It is approved to treat the following autoimmune diseases such as rheu... |
USD $15.00 | | | |
| 2 |
Apr, 2020 |
Trulicity Drug Sales & Forecast
Eli Lilly drug Trulicity, for the treatment of type 2 diabetes is approved in the United States and Europe in 2014 and Japan in 2015. MNG Tracker report t... |
USD $20.00 | | | |
| 3 |
Apr, 2020 |
Humalog Drug Sales & Forecast
Eli Lilly drug Humalog Mix75/25 and Humalog Mix50/50 are used to treat adults with diabetes for the control of high blood sugar. Its patent has expired in... |
USD $20.00 | | | |
| 4 |
Jun, 2020 |
AdroGel Drug Sales
AndroGel (testosterone gel) is a testosterone replacement therapy for males diagnosed with symptomatic low testosterone due to certain underlying conditio... |
USD $15.00 | | | |
| 5 |
Mar, 2020 |
Lynparza Drug Sales & Forecast
AstraZeneca drug Lynparza became the world’s ¬first approved PARP inhibitor in 2014. Initially indicated for the treatment of ovarian cancer, in 2017, ... |
USD $20.00 | | | |
| 6 |
Jun, 2020 |
Creon Drug Sales & Forecast
Creon (pancrelipase) is a pancreatic enzyme therapy for exocrine pancreatic insufficiency, a condition that occurs in patients with cystic fibrosis, chron... |
USD $15.00 | | | |
| 7 |
Jun, 2020 |
Viekira Pak Drug Sales
Viekira Pak is an all-oral, short-course, interferon-free therapy, with or without ribavirin, for the treatment of adult patients with genotype 1 chronic ... |
USD $15.00 | | | |
| 8 |
Mar, 2020 |
Imfinzi Drug Sales & Forecast
AstraZeneca drug Imfinzi is approved for lung and bladder cancer in 2017. Imfinzi, a human mAb that binds to PD-L1 and blocks the interaction of PD-L1 wit... |
USD $20.00 | | | |
| 9 |
Mar, 2020 |
Brilinta/Brilique Drug Sales & Forecast
Brilinta/Brilique (ticagrelor) is an oral antiplatelet for acute coronary syndromes (ACS). Brilinta/Brilique, one of AstraZeneca Growth Platforms, is an o... |
USD $20.00 | | | |
| 10 |
Mar, 2020 |
Crestor Drug Sales & Forecast
AstraZeneca drug Crestor is approved in more than 115 countries for the treatment of dyslipidaemia and hypercholesterolaemia. MNG Tracker report title “... |
USD $20.00 | | | |
| 11 |
Mar, 2020 |
Tagrisso Drug Sales & Forecast
AstraZeneca drug Tagrisso is approved for lung cancer in 2015. Tagrisso is a best-in-class, highly selective, irreversible inhibitor of the activating sen... |
USD $20.00 | | | |
| 12 |
Apr, 2020 |
Alimta Drug Sales & Forecast
Eli Lilly drug Alimta is used for the treatment of lung cancer. Its vitamin regimen patent plus pediatric exclusivity will expire in May 2022 in United St... |
USD $20.00 | | | |
| 13 |
Apr, 2020 |
Forteo Drug Sales & Forecast
Eli Lilly drug Forteo, for the treatment of osteoporosis in postmenopausal women and men at high risk for fracture and for glucocorticoid-induced osteopor... |
USD $20.00 | | | |
| 14 |
Apr, 2020 |
Basaglar Drug Sales & Forecast
Eli Lilly drug Basaglar (insulin glargine injection), a long-acting human insulin analog for the treatment of diabetes launched in the United Sates in 201... |
USD $20.00 | | | |
| 15 |
Apr, 2020 |
Atripla Drug Sales & Forecast
GileadSciences drug Atripla is an oral formulation indicated as a complete regimen for the treatment of HIV-1 infection in certain patients. Atripla is a ... |
USD $15.00 | | | |
| 16 |
Apr, 2020 |
Biktarvy Drug Sales & Forecast
GileadSciences drug Biktarvy is an oral formulation dosed once a day for the treatment of HIV-1 infection in certain patients. Biktarvy is a single tablet... |
USD $15.00 | | | |
| 17 |
Apr, 2020 |
Odefsey Drug Sales & Forecast
GileadSciences drug Odefsey is an oral formulation dosed once a day for the treatment of HIV-1 infection in certain patients. Odefsey is a single tablet r... |
USD $15.00 | | | |
| 18 |
Apr, 2020 |
Vemlidy Drug Sales & Forecast
GileadSciences drug Vemlidy is an oral formulation of TAF dosed once a day for the treatment of chronic hepatitis B virus (HBV) infection in adults with c... |
USD $15.00 | | | |
| 19 |
Apr, 2020 |
Vosevi Drug Sales & Forecast
GileadSciences drug Vosevi is an oral formulation of a once-daily, single tablet regimen of sofosbuvir, velpatasvir and voxilaprevir for the re-treatment ... |
USD $15.00 | | | |
| 20 |
Apr, 2020 |
Yescarta Drug Sales & Forecast
GileadSciences drug Yescarta (axicabtagene ciloleucel) is a (chimeric antigen receptor cell therapy) CAR-T for the treatment of adult patients with relaps... |
USD $15.00 | | | |
| 21 |
Apr, 2020 |
Benlysta Drug Sales & Forecast
GSK drug Benlysta is the world’s first and only biologic medicine specifically approved for adult and paediatric lupus to treat systemic lupus erythemat... |
USD $15.00 | | | |
| 22 |
Apr, 2020 |
Bexsero Vaccine Sales & Forecast
Since its launch in 2015, GSK Bexsero has become the industry-leading meningitis B vaccine. In the United States, where it is licensed for 10 to 25 year o... |
USD $15.00 | | | |
| 23 |
Apr, 2020 |
Juluca Drug Sales & Forecast
GSK received United States FDA approval for Juluca in 2017, a once-daily, single pill 2DR regimen for HIV. Juluca combines dolutegravir with rilpivirine (... |
USD $15.00 | | | |
| 24 |
Apr, 2020 |
Shingrix Vaccine Sales & Forecast
Shingrix marks a step change in the prevention of shingles, a painful and potentially serious illness. The vaccine addresses the age-related decline in im... |
USD $15.00 | | | |
| 25 |
Apr, 2020 |
Zejula Drug Sales & Forecast
Zejula, GlaxoSmithKline (GSK) oral PARP inhibitor, is approved in the United States and Europe for women with recurrent ovarian cancer. MNG Tracker report... |
USD $15.00 | | | |
| 26 |
Apr, 2020 |
Darzalex Drug Sales & Forecast
Johnson & Johnson drug Darzalex (daratumumab) is a prescription medicine used to treat a type of blood cancer called multiple myeloma. Darzalex is not che... |
USD $15.00 | | | |
| 27 |
Apr, 2020 |
Erleada Drug Sales & Forecast
Johnson & Johnson drug Erleada (apalutamide) is an androgen receptor (AR) inhibitor indicated for the treatment of patients with non-metastatic castration... |
USD $15.00 | | | |
| 28 |
Apr, 2020 |
Imbruvica Drug Sales & Forecast
Johnson & Johnson drug Imbruvica (ibrutinib) is an oral, once-daily medicine that works differently than chemotherapy as it blocks a protein called Bruton... |
USD $15.00 | | | |
| 29 |
Apr, 2020 |
Stelara Drug Sales & Forecast
Johnson & Johnson drug Stelara (ustekinumab), a treatment for adults and children with moderate to severe plaque psoriasis, for adults with active psoriat... |
USD $15.00 | | | |
| 30 |
Apr, 2020 |
Bridion Drug Sales & Forecast
Merck Bridion (sugammadex) Injection, a medication for the reversal of two types of neuromuscular blocking agents used during surgery. MNG Tracker report ... |
USD $15.00 | | | |
| 31 |
Apr, 2020 |
Gardasil/Gardasil 9 Vaccine Sales & Forecast
Merck Gardasil (Human Papillomavirus Quadrivalent [Types 6, 11, 16 and 18] Vaccine, Recombinant) and Gardasil 9 (Human Papillomavirus 9-valent Vaccine, Re... |
USD $15.00 | | | |
| 32 |
Apr, 2020 |
Keytruda Drug Sales & Forecast
Merck drug Keytruda is used for the treatment of multiple types of cancer such as non-small-cell lung cancer (NSCLC), small-cell lung cancer (SCLC), head ... |
USD $15.00 | | | |
| 33 |
Apr, 2020 |
ProQuad Vaccine Sales & Forecast
Merck ProQuad is a pediatric combination vaccine to protect against measles, mumps, rubella and varicella in children 12 months through 12 years of age. U... |
USD $15.00 | | | |
| 34 |
Apr, 2020 |
RotaTeq Vaccine Sales & Forecast
RotaTeq is a vaccine indicated for the prevention of rotavirus gastroenteritis (diarrhoea and vomiting) caused by rotavirus infections types G1, G2, G3, G... |
USD $15.00 | | | |
| 35 |
Apr, 2020 |
Varivax Vaccine Sales & Forecast
Merck Varivax is a vaccine indicated for active immunization for the prevention of varicella in individuals 12 months of age and older. The Food and Drug ... |
USD $15.00 | | | |
| 36 |
Apr, 2020 |
Chantix/Champix Drug Sales & Forecast
Chantix (also known as Champix in the EU and other countries) was approved by the FDA in May 2006 as a prescription medication that, along with support, h... |
USD $15.00 | | | |
| 37 |
Apr, 2020 |
Ibrance Drug Sales & Forecast
Pfizer drug Ibrance is used for the treatment of adult patients with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (H... |
USD $15.00 | | | |
| 38 |
Apr, 2020 |
Prevnar 13/Prevenar 13 Vaccine Sales & Forecast
Prevnar 13/Prevenar 13 is Pfizer vaccines for prevention of pneumococcal disease. In 2014, the Advisory Committee on Immunization Practices (ACIP) voted t... |
USD $15.00 | | | |
| 39 |
May, 2020 |
Xeljanz Drug Sales & Forecast
Pfizer drug Xeljanz (tofacitinib) is approved in the United States for adult patients in three indications: moderately to severely active rheumatoid arthr... |
USD $15.00 | | | |
| 40 |
May, 2020 |
Pfizer's Xtandi Drug Sales & Forecast
Pfizer drug Xtandi is FDA-approved for the treatment of non-metastatic and metastatic castration-resistant prostate cancer as well as metastatic castratio... |
USD $15.00 | | | |
| 41 |
May, 2020 |
Alecensa Drug Sales & Forecast
Roche drug Alecensa is a highly selective, CNS active, oral medicine created at Chugai Kamakura Research Laboratories and is being developed for people wi... |
USD $15.00 | | | |
| 42 |
May, 2020 |
Avastin Drug Sales & Forecast
Roche drug Avastin is a prescription-only medicine that is a solution for intravenous infusion. It is a biologic antibody designed to specifically bind to... |
USD $15.00 | | | |
| 43 |
May, 2020 |
Hemlibra Drug Sales & Forecast
Roche drug Hemlibra is a prophylactic (preventative) treatment that can be administered by an injection of a ready-to-use solution under the skin (subcuta... |
USD $15.00 | | | |
| 44 |
May, 2020 |
Herceptin Drug Sales & Forecast
Roche drug Herceptin (trastuzumab) is a humanized monoclonal antibody, designed to target and block the function of HER2, a protein produced by a specific... |
USD $15.00 | | | |
| 45 |
May, 2020 |
Kadcyla Drug Sales & Forecast
Roche drug Kadcyla is an antibody-drug conjugate (ADC) engineered to deliver potent chemotherapy directly to HER2-positive cancer cells, potentially limit... |
USD $15.00 | | | |
| 46 |
May, 2020 |
Ocrevus Drug Sales & Forecast
Roche drug Ocrevus (ocrelizumab) is the first and only therapy approved for both relapsing forms of multiple sclerosis (RMS) (including clinically isolate... |
USD $15.00 | | | |
| 47 |
May, 2020 |
Perjeta Drug Sales & Forecast
Roche drug Perjeta is given intravenously and targets the HER2 protein. It was approved in 2012 for the treatment of patients with advanced or late-stage ... |
USD $15.00 | | | |
| 48 |
May, 2020 |
Tecentriq Drug Sales & Forecast
Roche drug Tecentriq is a cancer immunotherapy that has the potential to be used as a foundational combination partner with other immunotherapies, targete... |
USD $15.00 | | | |
| 49 |
May, 2020 |
Aubagio Drug Sales & Forecast
Sanofi drug Aubagio (teriflunomide), a small molecule immunomodulatory agent with anti-inflammatory properties, is a once-daily oral therapy. In 2017, San... |
USD $15.00 | | | |
| 50 |
May, 2020 |
Cerezyme Drug Sales & Forecast
Sanofi drug Cerezyme (imiglucerase) is an enzyme replacement therapy used to treat Gaucher disease, an inherited and potentially life-threatening LSD. It ... |
USD $15.00 | | | |
| 51 |
May, 2020 |
Fabrazyme Drug Sales & Forecast
Sanofi drug Fabrazyme (agalsidase beta) is an enzyme replacement therapy used to treat Fabry disease, an inherited and potentially life threatening LSD. F... |
USD $15.00 | | | |
| 52 |
May, 2020 |
Dupixent Drug Sales & Forecast
Sanofi drug Dupixent (dupilumab), a human monoclonal antibody, binds to the interleukin-4 receptor (IL-4R) and has been shown to specifically inhibit over... |
USD $15.00 | | | |
| 53 |
May, 2020 |
Jevtana Drug Sales & Forecast
Sanofi drug Jevtana (cabazitaxel), a chemotherapy drug and cytotoxic agent, is a semi-synthetic second-generation taxane which prevents many cancer cells ... |
USD $15.00 | | | |
| 54 |
May, 2020 |
Lantus Drug Sales & Forecast
Sanofi drug Lantus is a long-acting analog of human insulin, indicated for once-daily administration for the treatment of diabetes mellitus in adults, ado... |
USD $15.00 | | | |
| 55 |
Jun, 2020 |
Lovenox/Clexane Drug Sales & Forecast
Sanofi drug Lovenox/Clexane (enoxaparin sodium) is a low molecular weight heparin (LMWH) for use in the prophylaxis and treatment of venous thromboembolis... |
USD $15.00 | | | |
| 56 |
Jun, 2020 |
Myozyme/Lumizyme Drug Sales & Forecast
Sanofi drug Myozyme/Lumizyme (alglucosidase alfa, intravenous infusion) are recombinant forms of the same human enzyme and are enzyme replacement therapie... |
USD $15.00 | | | |
| 57 |
Jun, 2020 |
Toujeo Drug Sales & Forecast
Toujeo is a solution for injection that contains the active substance insulin glargine. It is long-acting human insulin analogue indicated to improve glyc... |
USD $15.00 | | | |
| 58 |
Jun, 2020 |
Baraclude Drug Sales & Forecast
BMS drug Baraclude was first approved in March 2005 and subsequent approvals in Japan and the five major EU markets (France, Germany, Italy, Spain, and th... |
USD $15.00 | | | |
| 59 |
Jun, 2020 |
Eliquis Drug Sales & Forecast
BMS drug Eliquis (apixaban) is an oral Factor Xa inhibitor, targeted at stroke prevention in adult patients with NVAF and the prevention and treatment of ... |
USD $15.00 | | | |
| 60 |
Jun, 2020 |
Empliciti Drug Sales & Forecast
BMS and AbbVie jointly develop and commercialize Empliciti, a humanized monoclonal antibody for the treatment of multiple myeloma. Both parties participat... |
USD $15.00 | | | |
| 61 |
Jun, 2020 |
Opdivo/Yervoy Drug Sales & Forecast
Opdivo is a programmed death-1 (PD-1) immune checkpoint inhibitor that is designed to uniquely harness the body’s own immune system to help restore anti... |
USD $15.00 | | | |
| 62 |
Jun, 2020 |
Orencia Drug Sales & Forecast
BMS drug Orencia (abatacept), a biological product, is a fusion protein indicated for adult patients with moderately to severely active rheumatoid arthrit... |
USD $15.00 | | | |
| 63 |
Jun, 2020 |
Sprycel Drug Sales & Forecast
BMS drug Sprycel (dasatinib) is an oral inhibitor of multiple tyrosine kinase indicated for the first-line treatment of patients with Philadelphia chromos... |
USD $15.00 | | | |
All Drug LIST
